During the past decade, Medical Oncology Associates conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 12 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 2 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Medical Oncology Associates" #1 sponsor was "US Oncology Research" with 9 trials, followed by "Celgene" with 4 trials sponsored, "Bristol-Myers Squibb" with 2 trials sponsored, "Celgene Corporation" with 2 trials sponsored and "Eisai Inc." with 2 trials sponsored. Other sponsors include 7 different institutions and companies that sponsored additional 15 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Medical Oncology Associates" #1 collaborator was "Sanofi" with 3 trials as a collaborator, "Bristol-Myers Squibb" with 2 trials as a collaborator, "Pfizer" with 2 trials as a collaborator, "US Oncology Research" with 2 trials as a collaborator and "Astex Pharmaceuticals, Inc." with 1 trials as a collaborator. Other collaborators include 3 different institutions and companies that were collaborators in the rest 13 trials.

According to Clinical.Site data, the most researched conditions in "Medical Oncology Associates" are "Breast Cancer" (5 trials), "Metastatic Breast Cancer" (4 trials), "Small Cell Lung Cancer" (3 trials), "Multiple Myeloma" (2 trials) and "Prostate Cancer" (2 trials). Many other conditions were trialed in "Medical Oncology Associates" in a lesser frequency.

Most popular intervention types in "Medical Oncology Associates" are "Drug" (28 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "Amrubicin" (3 trials), "Carboplatin" (3 trials), "Cyclophosphamide" (3 trials), "Docetaxel" (3 trials) and "docetaxel" (3 trials). Other intervention names were less common.

The vast majority of trials in "Medical Oncology Associates" are 20 trials for "All" genders, 8 trials for "Female" genders and 3 trials for "Male" genders.

Currently, there are NaN active trials in "Medical Oncology Associates". undefined are not yet recruiting, undefined are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 24 completed trials in Medical Oncology Associates, undefined suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in Medical Oncology Associates, 0 "Phase 1" clinical trials were conducted, 10 "Phase 2" clinical trials and 18 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".